EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improving value of care for renal cell carcinoma patients; development of a decision aid for metastatic clear-cell renal cell carcinoma

Cato C Bresser, Harm H E van Melick, Regina The, Paul B van der Nat, Mirjam M Garvelink

Patient Education and Counseling · 2025

DOI: 10.1016/j.pec.2025.108800 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Patient Education and Counseling, 2025. Verfasst von Cato C Bresser und 4 weiteren Autor:innen. Beteiligte Einrichtung: St. Antonius Hospital, Dept. of Urology, Nieuwegein, the Netherlands; St. Antonius Hospital, Dept. of Value Improvement, Nieuwegein, the Netherlands;…. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Decision Support Techniques, Patient Participation. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MSD, Quality Funds Foundation of Medical Specialists, Bristol-Myers Squibb Company.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsDecision Support TechniquesPatient ParticipationDecision Making, SharedHumansMaleFemaleMiddle AgedAgedAdultNeeds AssessmentPatient-Centered CareDecision Making

Stichwörter der Autor:innen

Decision aidMetastatic clear-cell renal cell carcinomaShared decision-making

Autor:innen und Institutionen

  • St. Antonius Hospital, Dept. of Urology, Nieuwegein, the Netherlands; St. Antonius Hospital, Dept. of Value Improvement, Nieuwegein, the Netherlands; Radboudumc, IQ Health, Nijmegen, the Netherlands. Electronic address:…
  • St. Antonius Hospital, Dept. of Urology, Nieuwegein, the Netherlands.
  • ZorgKeuzeLab, Delft, the Netherlands.
  • St. Antonius Hospital, Dept. of Value Improvement, Nieuwegein, the Netherlands; Radboudumc, IQ Health, Nijmegen, the Netherlands.

Förderung

  • MSD
  • Quality Funds Foundation of Medical Specialists
  • Bristol-Myers Squibb Company
  • Ipsen Biopharmaceuticals
  • Pfizer BV

Zitieren

APA

Bresser, C. C., van Melick, H. H. E., The, R., van der Nat, P. B., & Garvelink, M. M. (2025). Improving value of care for renal cell carcinoma patients; development of a decision aid for metastatic clear-cell renal cell carcinoma. Patient Education and Counseling. https://doi.org/10.1016/j.pec.2025.108800

Vancouver

Bresser CC, van Melick HHE, The R, van der Nat PB, Garvelink MM. Improving value of care for renal cell carcinoma patients; development of a decision aid for metastatic clear-cell renal cell carcinoma. Patient Education and Counseling. 2025. doi:10.1016/j.pec.2025.108800

BibTeX
@article{Bresser2025,
  author = {Bresser, Cato C and van Melick, Harm H E and The, Regina and van der Nat, Paul B and Garvelink, Mirjam M},
  title = {Improving value of care for renal cell carcinoma patients; development of a decision aid for metastatic clear-cell renal cell carcinoma},
  journal = {Patient Education and Counseling},
  year = {2025},
  doi = {10.1016/j.pec.2025.108800}
}
Kostenlos starten →